Concurrence of polyostotic fibrous dysplasia and spinal aspergillus in non-immunocompromised adult patient

dc.contributor.authorAkatlı, Ayşe Nur
dc.contributor.authorYıldırım, İsmail Okan
dc.contributor.authorDurak, Mehmet Akif
dc.contributor.authorAladag, Mehmet Arif
dc.contributor.authorPasahan, Ramazan
dc.date.accessioned2024-08-04T19:54:35Z
dc.date.available2024-08-04T19:54:35Z
dc.date.issued2017
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAspergillus, a rare agent in spinal infections, is often transmitted via inhalation. It can be traced as an infectious agent in immunocompromised patients. While in non-immunocompromised patients, it is highly unlikely to cause spondylodiscitis. Radiological findings remind tuberculosis. The recommended medical treatment is applied with Itraconazole and Amphotericin B. Surgical indication involves the presence of progressive neurological deficit, instability and biopsy requirement. Fibrous dysplasia was first reported in 1938 by Lichtenstein and is a benign developmental disorder of the skeletal system with uncertain etiology. Polyostotic type involved more than one bone, while the monostotic type occurs by involving only one bone structure. Spinal involvement may lead to collapse fractures and deformity development and the most common complaint is pain.In our case, these two disorders occur concurrently, causing bone destruction and severe pain, and no similar cases were found in the literature.en_US
dc.identifier.endpage499en_US
dc.identifier.issn1300-1744
dc.identifier.issue4en_US
dc.identifier.startpage497en_US
dc.identifier.trdizinid270061en_US
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/270061
dc.identifier.urihttps://hdl.handle.net/11616/89963
dc.identifier.volume24en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofTurgut Özal Tıp Merkezi Dergisien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleConcurrence of polyostotic fibrous dysplasia and spinal aspergillus in non-immunocompromised adult patienten_US
dc.typeArticleen_US

Dosyalar